Page last updated: 2024-08-23

bucindolol and endothelin-1

bucindolol has been researched along with endothelin-1 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Burnett, JC; Frantz, RP; Grayburn, PA; Krause-Steinrauf, H; Krishnan, V; Lowes, BD; Uyeda, L; White, M	1
Bristow, MR; Cockroft, J; Humphrey, K; Lavori, P; Lazzeroni, LC; Mestroni, L; Slavov, D; Taylor, MR; Zhao, L; Zhu, X	1

Trials

2 trial(s) available for bucindolol and endothelin-1

Article	Year
Baseline and serial neurohormones in patients with congestive heart failure treated with and without bucindolol: results of the neurohumoral substudy of the Beta-Blocker Evaluation of Survival Study (BEST). Journal of cardiac failure, 2007, Volume: 13, Issue:6 Topics: Adrenergic beta-Antagonists; Aged; Atrial Natriuretic Factor; Biomarkers; Endothelin-1; Endothelins; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Propanolamines; Radioimmunoassay; Stroke Volume; Survival Rate; Treatment Outcome	2007
Pharmacogenetic effect of an endothelin-1 haplotype on response to bucindolol therapy in chronic heart failure. Pharmacogenetics and genomics, 2009, Volume: 19, Issue:1 Topics: Adrenergic beta-Antagonists; Aged; Aspartic Acid Endopeptidases; Endothelin-1; Endothelin-Converting Enzymes; Endothelins; Female; Haplotypes; Heart Failure; Humans; Linkage Disequilibrium; Male; Metalloendopeptidases; Middle Aged; Models, Genetic; Pharmacogenetics; Polymorphism, Single Nucleotide; Propanolamines; Proportional Hazards Models; Receptors, Endothelin	2009

Article

Year

Baseline and serial neurohormones in patients with congestive heart failure treated with and without bucindolol: results of the neurohumoral substudy of the Beta-Blocker Evaluation of Survival Study (BEST).

Journal of cardiac failure, 2007, Volume: 13, Issue:6

Topics: Adrenergic beta-Antagonists; Aged; Atrial Natriuretic Factor; Biomarkers; Endothelin-1; Endothelins; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Propanolamines; Radioimmunoassay; Stroke Volume; Survival Rate; Treatment Outcome

2007

Pharmacogenetic effect of an endothelin-1 haplotype on response to bucindolol therapy in chronic heart failure.

Pharmacogenetics and genomics, 2009, Volume: 19, Issue:1

Topics: Adrenergic beta-Antagonists; Aged; Aspartic Acid Endopeptidases; Endothelin-1; Endothelin-Converting Enzymes; Endothelins; Female; Haplotypes; Heart Failure; Humans; Linkage Disequilibrium; Male; Metalloendopeptidases; Middle Aged; Models, Genetic; Pharmacogenetics; Polymorphism, Single Nucleotide; Propanolamines; Proportional Hazards Models; Receptors, Endothelin

2009